Transforming Growth Factor Beta 1 Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드:1801431
리서치사:Lucintel
발행일:2025년 08월
페이지 정보:영문 150 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 형질전환 성장인자 베타1 시장 전망은 IPF와 암 시장의 기회로 인해 유망합니다. 세계 형질전환 성장인자 β1 시장은 2025-2031년 연평균 9.7%의 성장률을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 암 치료제에 대한 응용 연구 증가, 전 세계 섬유성 질환의 유병률 증가, 바이오 의약품 개발에 대한 투자 증가입니다.
Lucintel의 예측에 따르면, 유형별로는 피르페니돈이 예측 기간 동안 높은 성장세를 보일 것으로 예측됩니다.
용도별로는 암이 더욱 높은 성장세를 보일 것으로 예측됩니다.
지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.
형질전환 성장인자 베타1 시장의 새로운 트렌드
형질전환 성장인자 베타1 시장은 생명공학의 발전, 임상연구 증가, 질병 치료에 대한 적용 확대에 따라 진화하고 있습니다. 새로운 트렌드가 기술 혁신을 촉진하고 시장의 가능성을 확대하고 있습니다.
섬유증 치료에 대한 관심 증가: 연구개발은 섬유화 질환을 관리하기 위해 변형성장인자 베타1을 이용한 표적 치료제를 개발하고 있습니다. 이러한 추세는 간섬유증, 폐섬유증 등의 치료 옵션을 확대하고 있습니다.
암 면역치료의 역할 확대: 형질전환증식인자 베타1은 암 치료의 표적으로 연구되고 있으며, 면역치료 효과를 높이기 위해 새로운 억제제가 개발되고 있습니다. 이 연구는 새로운 암 치료제로 이어질 수 있는 연구입니다.
재생의료의 발전: 조직공학 및 줄기세포 치료에서 변형증식인자 베타1의 활용이 확대되고 있습니다. 상처 치유와 장기 재생에 중요한 역할을 하고 있습니다.
정밀의료 적용 확대: 형질전환증식인자 β1의 조절을 포함한 개인별 맞춤치료가 등장하고 있습니다. 연구진은 자가면역질환 및 염증성 질환의 치료법을 조정하는 데 있어서의 역할을 모색하고 있습니다.
정부 및 민간 부문의 자금 지원 증가: 생명공학 연구에 대한 투자가 증가하여 의약품 개발이 가속화되고 있습니다. 정부와 민간 기업은 새로운 의료 응용을 모색하는 프로젝트에 자금을 지원하고 있습니다.
이러한 추세는 치료용도 확대와 치료 정확도 향상을 통해 형질전환증식인자 베타1 시장을 재편하고 있습니다. 지속적인 연구와 투자를 통해 더 많은 기술 혁신이 이루어질 것으로 기대됩니다.
형질전환 성장인자 베타1 시장의 최근 동향
형질전환 성장인자 베타1 시장은 임상 연구, 의약품 개발, 규제 당국의 승인에 있어 괄목할 만한 진전을 보이고 있습니다. 이러한 개발은 치료 응용의 미래를 형성하고 있습니다.
암 치료제의 발전: 연구개발은 면역요법을 강화하기 위해 형질전환 성장인자 베타1 억제제를 개발하고 있습니다. 이러한 발전으로 암 치료 성적이 향상되고 있습니다.
섬유증 치료 연구의 진전: 폐섬유증과 간섬유증에 대한 형질전환증식인자 베타1을 표적으로 하는 약물의 임상시험이 진행되어 새로운 치료 가능성을 제시하고 있습니다.
재생의료 응용 확대: 줄기세포 치료 및 조직 재생에 있어 Transforming Growth Factor β1의 역할을 탐구하여 의료 혁신을 추진하고 있습니다.
임상시험에 대한 규제 당국의 승인 증가: 정부 및 보건 당국의 형질전환 성장인자 베타1 연구 지원은 더 많은 임상시험과 신약 승인으로 이어지고 있습니다.
생명공학 기업과 대학과의 협력 관계 확대: 산업계와의 제휴가 연구를 가속화하고, 변형증식인자 베타1을 기반으로 한 치료법의 혁신을 촉진하고 있습니다.
이러한 시장 개척은 치료용도 확대, 의약품 승인 가속화를 통해 형질전환 성장인자 베타1 시장에 변화를 가져오고 있습니다. 연구 자금 증가와 공동연구가 시장 성장의 원동력이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 개요
배경과 분류
공급망
제3장 시장 동향과 예측 분석
거시경제 동향과 예측
업계 촉진요인과 과제
PESTLE 분석
특허 분석
규제 환경
제4장 세계의 형질전환 성장인자 베타1 시장 : 유형별
개요
매력 분석 : 유형별
Pirfenidone : 동향과 예측(2019-2031년)
Galunisertib : 동향과 예측(2019-2031년)
기타 : 동향과 예측(2019-2031년)
제5장 세계의 형질전환 성장인자 베타1 시장 : 용도별
개요
매력 분석 : 용도별
IPF : 동향과 예측(2019-2031년)
암 : 동향과 예측(2019-2031년)
기타 : 동향과 예측(2019-2031년)
제6장 지역 분석
개요
세계의 형질전환 성장인자 베타1 시장 : 지역별
제7장 북미의 형질전환 성장인자 베타1 시장
개요
북미의 형질전환 성장인자 베타1 시장 : 유형별
북미의 형질전환 성장인자 베타1 시장 : 용도별
미국의 형질전환 성장인자 베타1 시장
멕시코의 형질전환 성장인자 베타1 시장
캐나다의 형질전환 성장인자 베타1 시장
제8장 유럽의 형질전환 성장인자 베타1 시장
개요
유럽의 형질전환 성장인자 베타1 시장 : 유형별
유럽의 형질전환 성장인자 베타1 시장 : 용도별
독일의 형질전환 성장인자 베타1 시장
프랑스의 형질전환 성장인자 베타1 시장
스페인의 형질전환 성장인자 베타1 시장
이탈리아의 형질전환 성장인자 베타1 시장
영국의 형질전환 성장인자 베타1 시장
제9장 아시아태평양의 형질전환 성장인자 베타1 시장
개요
아시아태평양의 형질전환 성장인자 베타1 시장 : 유형별
아시아태평양의 형질전환 성장인자 베타1 시장 : 용도별
일본의 형질전환 성장인자 베타1 시장
인도의 형질전환 성장인자 베타1 시장
중국의 형질전환 성장인자 베타1 시장
한국의 형질전환 성장인자 베타1 시장
인도네시아의 형질전환 성장인자 베타1 시장
제10장 기타 지역(ROW)의 형질전환 성장인자 베타1 시장
개요
기타 지역(ROW)의 형질전환 성장인자 베타1 시장 : 유형별
기타 지역(ROW)의 형질전환 성장인자 베타1 시장 : 용도별
중동의 형질전환 성장인자 베타1 시장
남미의 형질전환 성장인자 베타1 시장
아프리카의 형질전환 성장인자 베타1 시장
제11장 경쟁 분석
제품 포트폴리오 분석
운영 통합
Porter의 Five Forces 분석
경쟁 기업간 경쟁 관계
바이어의 교섭력
공급업체의 교섭력
대체품의 위협
신규 진출업체의 위협
시장 점유율 분석
제12장 기회와 전략 분석
밸류체인 분석
성장 기회 분석
성장 기회 : 유형별
성장 기회 : 용도별
세계 형질전환 성장인자 베타1 시장의 새로운 동향
전략 분석
신제품 개발
인증 및 라이선싱
인수합병(M&A), 계약, 제휴 및 합작투자(JV)
제13장 밸류체인 주요 기업 개요
경쟁 분석
Roche
Shionogi
Acceleron Pharma
Genzyme
Isarna Therapeutics
Scholar Rock
Sirnaomics
제14장 부록
그림 리스트
표 리스트
분석 방법
면책사항
저작권
약어와 기술 단위
Lucintel에 대해
문의
LSH
영문 목차
영문목차
The future of the global transforming growth factor beta 1 market looks promising with opportunities in the IPF and cancer markets. The global transforming growth factor beta 1 market is expected to grow with a CAGR of 9.7% from 2025 to 2031. The major drivers for this market are the increasing research in cancer therapeutics applications, the rising prevalence of fibrotic diseases globally, and the growing investment in biotechnology drug development.
Lucintel forecasts that, within the type category, pirfenidone is expected to witness higher growth over the forecast period.
Within the application category, cancer is expected to witness higher growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market is evolving with advancements in biotechnology, increased clinical research, and growing applications in disease treatment. Emerging trends are driving innovation and expanding market potential.
Increased Focus on Fibrosis Treatment: Researchers are developing targeted therapies using transforming growth factor beta 1 to manage fibrotic diseases. This trend is expanding treatment options for conditions such as liver fibrosis and pulmonary fibrosis.
Growing Role in Cancer Immunotherapy: Transforming growth factor beta 1 is being explored as a target in cancer treatment, with new inhibitors being developed to improve immunotherapy effectiveness. This research is leading to new oncology drugs.
Advancements in Regenerative Medicine: The use of transforming growth factor beta 1 in tissue engineering and stem cell therapy is growing. It is playing a crucial role in wound healing and organ regeneration.
Expansion in Precision Medicine Applications: Personalized therapies involving transforming growth factor beta 1 modulation are emerging. Researchers are exploring its role in tailoring treatments for autoimmune and inflammatory diseases.
Increasing Government and Private Sector Funding: Rising investments in biotechnology research are accelerating drug development. Governments and private firms are funding projects to explore new medical applications.
These trends are reshaping the transforming growth factor beta 1 market by expanding its therapeutic applications and enhancing treatment precision. Continued research and investment are expected to drive further innovations.
Recent Developments in the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market is experiencing significant advancements in clinical research, drug development, and regulatory approvals. These developments are shaping the future of therapeutic applications.
Advancement in Cancer Therapeutics: Researchers are developing transforming growth factor beta 1 inhibitors to enhance immunotherapy. These advancements are improving cancer treatment outcomes.
Progress in Fibrosis Treatment Research: Clinical trials are evaluating transforming growth factor beta 1-targeted drugs for pulmonary and liver fibrosis, offering new treatment possibilities.
Expansion of Regenerative Medicine Applications: Scientists are exploring transforming growth factor beta 1's role in stem cell therapy and tissue regeneration, advancing medical innovation.
Increased Regulatory Approvals for Clinical Trials: Governments and health authorities are supporting research on transforming growth factor beta 1, leading to more clinical trials and new drug approvals.
Growing Collaborations Between Biotech Companies and Universities: Industry partnerships are accelerating research, driving innovation in transforming growth factor beta 1-based therapies.
These developments are transforming the transforming growth factor beta 1 market by expanding its therapeutic applications and accelerating drug approvals. Increased research funding and collaborations are driving market growth.
Strategic Growth Opportunities in the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market presents significant growth opportunities across various applications. Advancements in regenerative medicine, oncology, and fibrosis treatment are creating new possibilities for market expansion.
Development of Anti-Fibrotic Therapies: The rising prevalence of fibrotic diseases is driving demand for transforming growth factor beta 1 inhibitors, offering new market opportunities in pulmonary and liver fibrosis treatment.
Expansion in Cancer Immunotherapy Research: Transforming growth factor beta 1 modulation is improving immunotherapy outcomes, creating opportunities for new oncology drug development.
Advancements in Stem Cell Therapy Applications: The integration of transforming growth factor beta 1 in stem cell-based treatments is enhancing wound healing and tissue regeneration.
Increasing Use in Autoimmune Disease Treatment: Researchers are exploring the role of transforming growth factor beta 1 in regulating immune responses, creating growth potential in autoimmune therapy.
Growing Investment in Personalized Medicine: The role of transforming growth factor beta 1 in precision medicine is expanding, allowing for the development of targeted therapies for specific patient populations.
These growth opportunities highlight the expanding role of transforming growth factor beta 1 in modern medicine. Continued research and investment are expected to drive innovation and broaden its therapeutic applications.
Transforming Growth Factor Beta 1 Market Driver and Challenges
The transforming growth factor beta 1 market is influenced by various drivers and challenges, including advancements in medical research, regulatory policies, and economic factors. These elements shape the market's growth and application potential.
The factors responsible for driving the transforming growth factor beta 1 market include:
1. Rising Demand for Regenerative Medicine: Increasing interest in tissue engineering and stem cell therapy is driving the demand for transforming growth factor beta 1 in regenerative medicine applications.
2. Growing Investments in Oncology Research: Pharmaceutical companies are funding research on transforming growth factor beta 1 inhibitors for cancer treatment, expanding market opportunities.
3. Advancements in Drug Development Technologies: Innovations in biotechnology are enabling the development of targeted therapies using transforming growth factor beta 1, improving treatment effectiveness.
4. Supportive Government Policies for Biotechnology Research: Governments worldwide are funding biotechnology projects, accelerating research on transforming growth factor beta 1 applications.
5. Expansion of Clinical Trials in Fibrosis and Cancer Therapy: Increasing clinical trials exploring transforming growth factor beta 1's role in disease treatment are driving market growth and drug development.
Challenges in the transforming growth factor beta 1 market are:
1. Regulatory Complexities and Approval Delays: The stringent approval process for new transforming growth factor beta 1 therapies poses a challenge to market entry and commercialization.
2. High Research and Development Costs: The cost-intensive nature of transforming growth factor beta 1 research limits investment by smaller biotech firms, slowing market expansion.
3. Potential Side Effects and Safety Concerns: Managing the adverse effects of transforming growth factor beta 1 modulation in therapeutic applications remains a significant challenge in drug development.
The transforming growth factor beta 1 market is growing due to increased research, regulatory support, and advancements in medical applications. However, challenges such as regulatory hurdles, high costs, and safety concerns must be addressed for sustained market growth.
List of Transforming Growth Factor Beta 1 Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transforming growth factor beta 1 companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transforming growth factor beta 1 companies profiled in this report include-
Roche
Shionogi
Acceleron Pharma
Genzyme
Isarna Therapeutics
Scholar Rock
Sirnaomics
Transforming Growth Factor Beta 1 Market by Segment
The study includes a forecast for the global transforming growth factor beta 1 market by type, application, and region.
Transforming Growth Factor Beta 1 Market by Type [Value from 2019 to 2031]:
Pirfenidone
Galunisertib
Others
Transforming Growth Factor Beta 1 Market by Application [Value from 2019 to 2031]:
IPF
Cancer
Others
Transforming Growth Factor Beta 1 Market by Region [Value from 2019 to 2031]:
North America
Europe
Asia Pacific
The Rest of the World
Country Wise Outlook for the Transforming Growth Factor Beta 1 Market
The transforming growth factor beta 1 market is evolving with advancements in biotechnology, increased clinical research, and growing applications in disease treatment. Emerging trends are driving innovation and expanding market potential.
Increased Focus on Fibrosis Treatment: Researchers are developing targeted therapies using transforming growth factor beta 1 to manage fibrotic diseases. This trend is expanding treatment options for conditions such as liver fibrosis and pulmonary fibrosis.
Growing Role in Cancer Immunotherapy: Transforming growth factor beta 1 is being explored as a target in cancer treatment, with new inhibitors being developed to improve immunotherapy effectiveness. This research is leading to new oncology drugs.
Advancements in Regenerative Medicine: The use of transforming growth factor beta 1 in tissue engineering and stem cell therapy is growing. It is playing a crucial role in wound healing and organ regeneration.
Expansion in Precision Medicine Applications: Personalized therapies involving transforming growth factor beta 1 modulation are emerging. Researchers are exploring its role in tailoring treatments for autoimmune and inflammatory diseases.
Increasing Government and Private Sector Funding: Rising investments in biotechnology research are accelerating drug development. Governments and private firms are funding projects to explore new medical applications.
Features of the Global Transforming Growth Factor Beta 1 Market
Market Size Estimates: Transforming growth factor beta 1 market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Transforming growth factor beta 1 market size by type, application, and region in terms of value ($B).
Regional Analysis: Transforming growth factor beta 1 market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the transforming growth factor beta 1 market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transforming growth factor beta 1 market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the transforming growth factor beta 1 market by type (pirfenidone, galunisertib, and others), application (IPF, cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain
3. Market Trends & Forecast Analysis
3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment
4. Global Transforming Growth Factor Beta 1 Market by Type
4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Pirfenidone: Trends and Forecast (2019-2031)
4.4 Galunisertib: Trends and Forecast (2019-2031)
4.5 Others: Trends and Forecast (2019-2031)
5. Global Transforming Growth Factor Beta 1 Market by Application
5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 IPF: Trends and Forecast (2019-2031)
5.4 Cancer: Trends and Forecast (2019-2031)
5.5 Others: Trends and Forecast (2019-2031)
6. Regional Analysis
6.1 Overview
6.2 Global Transforming Growth Factor Beta 1 Market by Region
7. North American Transforming Growth Factor Beta 1 Market
7.1 Overview
7.2 North American Transforming Growth Factor Beta 1 Market by Type
7.3 North American Transforming Growth Factor Beta 1 Market by Application
7.4 United States Transforming Growth Factor Beta 1 Market
